S. R. Schwid

1.6k total citations
17 papers, 1.2k citations indexed

About

S. R. Schwid is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, S. R. Schwid has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 4 papers in Oncology and 3 papers in Neurology. Recurrent topics in S. R. Schwid's work include Multiple Sclerosis Research Studies (10 papers), Acute Lymphoblastic Leukemia research (3 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). S. R. Schwid is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Acute Lymphoblastic Leukemia research (3 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). S. R. Schwid collaborates with scholars based in United States, Netherlands and Ireland. S. R. Schwid's co-authors include Andrew Goodman, Michael McDermott, David H. Mattson, S. D. Cook, David Mason, Charles A. Thornton, Mohammed Sanjak, S. Pandya, Lauren Krupp and J. A. Cohen and has published in prestigious journals such as American Journal of Clinical Nutrition, Neurology and Multiple Sclerosis Journal.

In The Last Decade

S. R. Schwid

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. R. Schwid United States	14	850	377	228	205	143	17	1.2k
María Fernanda Mendes Brazil	15	323 0.4×	187 0.5×	107 0.5×	47 0.2×	40 0.3×	54	835
Devon Conway United States	15	590 0.7×	173 0.5×	66 0.3×	122 0.6×	43 0.3×	63	822
O Lyon-Caen France	12	387 0.5×	187 0.5×	135 0.6×	163 0.8×	52 0.4×	35	835
Sebastian Schimrigk Germany	22	602 0.7×	248 0.7×	65 0.3×	86 0.4×	32 0.2×	42	1.1k
Teresa Costabile Italy	16	447 0.5×	186 0.5×	53 0.2×	75 0.4×	30 0.2×	34	709
Arjan Malekzadeh Netherlands	12	175 0.2×	123 0.3×	87 0.4×	50 0.2×	23 0.2×	32	753
Gerald Garmany United Kingdom	6	506 0.6×	194 0.5×	75 0.3×	169 0.8×	57 0.4×	10	731
Patricia Dickson United States	23	118 0.1×	84 0.2×	95 0.4×	374 1.8×	72 0.5×	109	1.9k
A. Rombos Greece	15	204 0.2×	310 0.8×	49 0.2×	91 0.4×	26 0.2×	24	845
Jaspreet Pannu United States	15	370 0.4×	41 0.1×	56 0.2×	90 0.4×	28 0.2×	28	1.3k

Countries citing papers authored by S. R. Schwid

Since Specialization

Citations

This map shows the geographic impact of S. R. Schwid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. R. Schwid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. R. Schwid more than expected).

Fields of papers citing papers by S. R. Schwid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. R. Schwid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. R. Schwid. The network helps show where S. R. Schwid may publish in the future.

Co-authorship network of co-authors of S. R. Schwid

This figure shows the co-authorship network connecting the top 25 collaborators of S. R. Schwid. A scholar is included among the top collaborators of S. R. Schwid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. R. Schwid. S. R. Schwid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Noyes, Katia, Alina Bajorska, S. R. Schwid, et al.. (2011). Cost-effectiveness of disease-modifying therapy for multiple sclerosis. Neurology. 77(4). 355–363. 77 indexed citations

Rudick, RA, CH Polman, JA Cohen, et al.. (2009). Assessing disability progression with the Multiple Sclerosis Functional Composite. Multiple Sclerosis Journal. 15(8). 984–997. 75 indexed citations

Goodman, Andrew, J. A. Cohen, Lauren Krupp, et al.. (2008). Dose comparison trial of sustained-release fampridine in multiple sclerosis. Neurology. 71(15). 1134–1141. 145 indexed citations

Dorsey, E. Ray, et al.. (2007). Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis. Neurology. 68(18). 1524–1528. 17 indexed citations

Goetz, Christopher G., et al.. (2006). Safety of rasagiline in elderly patients with Parkinson disease. Neurology. 66(9). 1427–1429. 34 indexed citations

Schwid, S. R., et al.. (2004). A reply to the letter Cognitive fatigue in multiple sclerosis by Kos D, Kerchkofs E, Nagels G, Geentjens L. Multiple Sclerosis Journal. 10(3). 338–338. 1 indexed citations

Schwid, S. R., et al.. (2002). Quantitative functional measures in MS: What is a reliable change?. Neurology. 58(8). 1294–1296. 157 indexed citations

Schwid, S. R., Andrew Goodman, Brian R. Apatoff, et al.. (2000). Are quantitative functional measures more sensitive to worsening MS than traditional measures?. Neurology. 55(12). 1901–1903. 29 indexed citations

Schwid, S. R., Charles A. Thornton, S. Pandya, et al.. (1999). Quantitative assessment of motor fatigue and strength in MS. Neurology. 53(4). 743–743. 187 indexed citations

10.

Schwid, S. R., et al.. (1999). Neurology in the Tropics. Neurology. 53(5). 1162–1162. 7 indexed citations

11.

Schwid, S. R., Andrew Goodman, & David H. Mattson. (1997). Autoimmune Hyperthyroidism in Patients With Multiple Sclerosis Treated With Interferon Beta-1b. Archives of Neurology. 54(9). 1169–1170. 51 indexed citations

12.

Schwid, S. R., et al.. (1997). The measurement of ambulatory impairment in multiple sclerosis. Neurology. 49(5). 1419–1424. 91 indexed citations

13.

Schwid, S. R.. (1997). Handbook of Multiple Sclerosis. Archives of Neurology. 54(12). 1452–1452. 25 indexed citations

14.

Schwid, S. R., et al.. (1997). Quantitative assessment of sustained‐release 4‐aminopyridine for symptomatic treatment of multiple sclerosis. Neurology. 48(4). 817–820. 173 indexed citations

15.

Schwid, S. R., Andrew Goodman, J. Edward Puzas, Michael McDermott, & David H. Mattson. (1996). Sporadic Corticosteroid Pulses and Osteoporosis in Multiple Sclerosis. Archives of Neurology. 53(8). 753–757. 77 indexed citations

16.

Schwid, S. R., et al.. (1996). Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis. Multiple Sclerosis Journal. 2(5). 252–252. 4 indexed citations

17.

Schwid, S. R., et al.. (1992). Nicotine effects on body weight: a regulatory perspective. American Journal of Clinical Nutrition. 55(4). 878–884. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact